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Abstract
Objective: To elicit the views of well- informed community members on the accepta-
bility of proposed policy interventions designed to improve community use of antibi-
otics in Australia.
Design: Two community juries held in 2016.
Setting and participants: Western Sydney and Dubbo communities in NSW, Australia. 
Twenty- nine participants of diverse social and cultural backgrounds, mixed genders 
and ages recruited via public advertising: one jury was drawn from a large metropoli-
tan setting; the other from a regional/rural setting.
Main outcome measure: Jury verdict and rationale in response to a prioritization task 
and structured questions.
Results: Both juries concluded that potential policy interventions to curb antibiotic 
misuse in the community should be directed towards: (i) ensuring that the public and 
prescribers were better educated about the dangers of antibiotic resistance; (ii) making 
community- based human and animal health- care practitioners accountable for their 
prescribing decisions. Patient- centred approaches such as delayed prescribing were 
seen as less acceptable than prescriber- centred approaches; both juries completely 
rejected any proposal to decrease consumer demand by increasing antibiotic prices.
Conclusion: These informed citizens acknowledged the importance of raising public 
awareness of the risks, impacts and costs of antibiotic resistance and placed a high 
priority on increasing social and professional accountability through restrictive 
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1  | INTRODUCTION
Antimicrobial resistance (AMR) is a significant threat to human health 
and well- being.1 AMR affects the lives and livelihoods of millions 
globally by disrupting health, agricultural and ecological systems.2 
Antibiotic use is a key driver of AMR—the more antibiotics we use, the 
more likely it is that resistance will develop, be amplified and spread.3 
Following publication of the O’Neill Report, the costs of failing to 
address the challenges of AMR are becoming clearer and strategies 
to address AMR have been elevated on national and global political 
 agendas—including developing a global action plan.4 As their effec-
tiveness declines and antibiotics become a limited resource, it is in-
creasingly clear that further escalations in the level of AMR will lead to 
broad, sustained and adverse impacts on the health and well- being of 
individuals and their communities.
Governments, professional groups and industry stakeholders in 
Australia have long recognized that curbing antibiotic misuse is essen-
tial to fostering sustainable health- care and agricultural systems.5 Until 
recently, measures taken in Australia to counter AMR have focused 
on changing prescriber and consumer expectations and behaviours. 
Professional bodies and health regulators have emphasized: public edu-
cation campaigns for health- care providers and consumers;6 the institu-
tion of antibiotic stewardship programmes in hospitals;7 and restricting 
access to key classes of antibiotics.8 Recent reports from Australian 
Government agencies indicate that significant progress has been made 
in limiting unnecessary or high- risk antibiotic use in agriculture9 and 
inappropriate antibiotic prescribing in hospital settings.10 However, de-
spite concerted efforts to promote rational antimicrobial use, Australia 
continues to have one of the highest rates of community use of antibi-
otics in the world. In Australia, antibiotics are almost entirely sourced 
from community- based human and animal health- care providers such 
as general practitioners (GPs), dentists and veterinarians. While available 
data indicate that per head, the use of antibiotics for animal health is 
very low by international standards,11 recent reports indicate human 
antibiotic use in Australia is twice that of comparable countries (eg, 
the Netherlands and Sweden), with no measurable population health 
benefit.10
In June 2015, the National Antimicrobial Resistance Strategy 2015-
2019 was jointly launched by the Australian Federal Government 
Ministers of Health and Agriculture12 following extended cross- 
sectoral consultation. The first two objectives of this seven- point plan 
are to:
1. Increase awareness and understanding of AMR through effective 
communication, education and training; and
2. Implement effective stewardship programmes across human and 
animal health care to ensure judicious antimicrobial use.
The focus of early action is attenuating demand for antibiotics, while 
providing practitioners with support to prescribe appropriately through 
creation of guidelines and decision tools. While the measures introduced 
under the auspices of the National Antimicrobial Resistance Strategy are not 
overly restrictive and do not directly impinge on practitioner’s clinical auton-
omy, moves towards implementation have encouraged debate within the 
Australian health system and consideration of a range of policy interventions 
and new approaches to managing antibiotic misuse in community settings.
Globally, the problem of AMR is increasingly conceptualized as one 
of supply and demand. Efforts to increase supply are focused on in-
centivizing therapeutic innovation.4 Efforts to attenuate demand are 
typically focused on education and reducing uncertainty by developing 
improved diagnostic methods. Despite the logic and appeal of focus-
ing on prescriber and public education about AMR, efforts so far have 
not delivered the desired impacts.13 Systematic evaluations of educa-
tion campaigns on rational medicine use show their effects are typically 
short- lived.14 Because the social norms, incentives and structures that 
drive misuse of medicines almost always remain unchanged, providers 
and consumers soon revert to previous behaviours once the interven-
tion ends. The disappointing results of educational interventions have 
led economists, ethicists and public health practitioners to focus on fea-
tures of demand- side economics—such as price elasticity and opportu-
nity costs—by proposing a tax on antibiotic use,15,16 especially in sectors 
that are more price- sensitive such as animal health and agriculture.17
Responding to the need to curb antibiotic overuse and misuse, 
researchers around the world have been trialing more restrictive 
measures and clinician- and patient- centred behavioural interven-
tions. Policies aimed at postponing access to antibiotics for “low risk” 
or otherwise demanding patients include post- dated or delayed pre-
scribing.14,18 Interventions aimed at changing clinical decision making 
include surveillance and peer- monitoring of prescribers.19,20 At their 
most restrictive, these involve requiring providers to write a justifi-
cation on the patient record every time antibiotics are prescribed.20 
This is being contrasted with the effectiveness of less restrictive mea-
sures such as encouraging consumers and practitioners to be mindful 
of AMR by displaying in waiting rooms a “practitioner’s pledge” to only 
prescribe antibiotics when needed.21
measures. Their overarching aim was that policy interventions should be directed to-
wards creating collective actions and broad social support for changing antibiotic use 
through establishing and explaining the need for mechanisms to control and support 
better prescribing by practitioners, while not transferring the burdens, costs and risks 
of interventions to consumers.
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Clearly, most of the proposed policy remedies described above 
are not cost or effort neutral. Some are likely to be burdensome and 
contentious in that they will intentionally, and sometimes coercively, 
impose new costs on some for the benefit of others.22 Because many 
of the proposed interventions for dealing with AMR also raise ques-
tions of fairness, legitimacy, and the common good, implementing them 
successfully is likely to require significant levels of public support and 
understanding.23
We report on two community juries convened in 2016 to consider 
how to make antibiotic use in Australia more sustainable. A community 
jury (similar to the proprietary method Citizens’ Juries) is a group of cit-
izens brought together to receive detailed evidence about and deliber-
ate on a specific issue. Community juries have been used in Australia 
and elsewhere to consider complex and contentious issues surround-
ing health resource prioritization and the introduction of new health 
technologies.24 Our aim was not to capture front- of- mind opinions, 
but rather to ascertain what a well- informed citizenry would accept 
as legitimate policy interventions to curb antibiotic misuse, and why. 
Community juries are an established, appropriate method to achieve 
this.25 Community juries are designed to promote participant inclusiv-
ity and deliberative participation rather than statistical representation. 
For this reason, a jury is typically comprised of 12- 15 people so that 
the quality of participation and deliberation is optimized.26,27 Unlike 
surveys and focus groups, they involve extensive provision of informa-
tion, constructive, structured dialogue between publics and experts, 
and adequate time for consideration. The method assumes that peo-
ple can think rationally and change their views should the evidence 
warrant it. The process is like a legal proceeding, but the outputs are 
not legally binding: instead, they provide evidence for policymaking.
We consulted relevant policymakers (representatives of the Office 
of Health Protection, Australian Commission on Safety and Quality in 
Health Care, Department of Agriculture) to design the questions juries 
would consider (Box 1). All agreed the key issue to be explored was 
how we should limit antibiotic use in the Australian community. Based 
on this consultation and review of the available policy, peer- reviewed 
and grey literatures, seven interventions were chosen for the juries to 
consider.14,28 In the light of work currently being undertaken as part of 
the National Antimicrobial Resistance Strategy,12 we sought information 
on what selected members of the public, from metropolitan and re-
gional/rural settings, consider to be the most fair and legitimate means 
of antibiotic use in the Australian community, and what other policy 
measures they thought should also be considered. Our study was ap-
proved by HREC:BLINDED.
2  | METHODS
Community juries are a deliberative method, with these general 
characteristics:
1. A group of citizens is convened for 1-3 days;
2. They are asked to consider a specific issue;
3. They hear evidence from, and ask question of (often opposed) 
experts;
Box 1 The questions posed to juries
Antibiotics are often used when they are not needed. If this situation continues, antibiotics will no longer be effective when they are needed 
to treat a serious infection that could be fatal without effective treatment. The following measures have been proposed to help make sure 
that antibiotics continue to be effective when we really need them.
1. Educate prescribers and the public on appropriate antibiotic use.
2. Make antibiotics significantly more expensive (this additional cost would sometimes be paid by the consumer and sometimes by the 
taxpayer).
3. Prohibit antibiotics from being dispensed on the day of prescription (ie, require them to be dispensed 3 or more days later)—this could 
apply to prescriptions written by GPs, veterinarians and/or dentists.
4. Prohibit or severely restrict community-based practitioners such as GPs, veterinarians and/or dentists from prescribing antibiotics of last resort.
5. Ban the use of growth promoting antibiotics in food-producing animals.
6. Ask GPs, veterinarians and/or dentists to hang a signed poster in their consulting room pledging to only prescribe antibiotics when they 
are needed.
7. Require GPs, veterinarians and/or dentists to write a justification on the patient’s record each time they prescribe antibiotics.
Part A: Are there any other measures to promote sustainable antibiotic use that the jury thinks should be added to the list for 
consideration?
In Part B, you will decide which of these seven measures is the best way to make antibiotic use more sustainable. Before you rank these 
seven measures, you may want to add more to the list.
Part B: In this task, we are asking the jury to reorganize the list of measures. Put the best measure to make antibiotic use more sustainable 
at the top, and the worst measure at the bottom. Put all of the measures in order, from best to worst. Please carefully record the reasons for 
your decisions.
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4. They are given time for deliberation, and to come to a conclusion, 
which is documented.
There are two main approaches to community juries. In the first, 
participants work as a group to draft open sets of recommendations 
on an issue; in the second, jury members vote on options presented by 
researchers.29 We used a combined approach. Each jury was presented 
with the same list of seven options, followed by a two- part question for 
consideration. In Part A of the question, jurors were asked to nominate 
three policy interventions worthy of consideration but not listed; in Part 
B, they were then asked to prioritize all ten interventions relative to each 
other and give reasons for their decisions (Box 1).
2.1 | Recruitment and selection
We recruited two Community Juries, of both genders and a range of 
ages (Table 1). We placed advertisements and stories in mass and social 
media in the Western Sydney and Central Plains areas of NSW Australia. 
Western Sydney is a large multicultural urban community of 2 million 
people; Dubbo is a regional centre of 37 000 people and one of the 
agricultural hubs of central NSW. Metropolitan and regional/rural sites 
for the juries were chosen because changing the availability and uses of 
antibiotics has different implications for individuals and their communi-
ties in each setting. Changing how antibiotics can be used in agricultural 
industries, for example, will require an overhaul of animal production 
systems in rural communities which will likely also lead to the repricing 
of many foods in urban settings. At the level of individual experiences 
patients in regional and remote communities often need to wait longer 
and travel much further to see a community- based health professional 
than people living in a large city, so any additional barrier to accessing 
antibiotics may place additional burdens on these individuals.
Of 82 responders 32 could not commit or were not available. Six 
were ineligible because they or a close family member had prescribing 
authority or had recently worked for a pharmaceutical company. Of the 
remaining sample we recruited 30 jurors (15 from each area) based on 
their eligibility, socio- demographic characteristics and availability. We 
sought socioeconomic and cultural diversity across juries. The jury in 
Western Sydney was more socio- culturally diverse than the jury in Dubbo 
reflecting the composition of these communities; both juries broadly 
matched the average educational attainment in the Australian popula-
tion (Table 1). All jurors received a modest honorarium in recognition of 
their participation and contribution to jury processes and outcomes.
Each jury commenced with an orientation session, to introduce 
the process and questions for consideration. Participant’s queries or 
concerns were addressed during this introductory session, at the end 
of which written consent was sought and received from each juror. 
Jury Day 1 (Saturday) focused on interrogating the evidence and un-
derstanding the ethical, legal and practical issues. Jurors were first 
shown a documentary (30 minute) on the nature of antibiotic resis-
tance, produced by the Science Unit of the Australian Broadcasting 
Corporation.30 Testimony from a range of relevant experts was pre- 
recorded and shown to jurors as video presentations. Experts were 
selected on the basis of their institutional roles, experience and 
expertise. Expert testimony and jury process were explicitly designed 
around providing jurors with balanced and factual information rather 
than creating oppositions—ie, a case “for” or “against” adopting spe-
cific interventions. Through these presentations, jurors were provided 
with expert reviews of: (i) the current regulatory landscape surrounding 
antibiotic use in Australia, (ii) the nature and mechanism of each of the 
seven proposed policy interventions; and (iii) the purpose, context and 
benefits and harms of antibiotic use in community- based human, ani-
mal and dental health- care practices (Table 2). As part of their witness 
briefs, all of the professional experts were also asked to draw on their 
expertise and the best available evidence to describe the likely impacts 
and implications of each of the proposed policy interventions for their 
prescriber group, patients and the broader community. Each presenta-
tion ran for ~20 minutes. Pre- recording ensured the format of the evi-
dence presented was standardized. Each expert’s bio- sketch (including 
TABLE  1 Characteristics of jury participants
Jury 1 (n=14a) Jury 2 (n=15)
Age (y)
<40 4 6
40- 70 7 8
>70 3 1
Range 25- 71 23- 70
Median 49.3 47.7
Gender
Male 6 6
Female 8 9
Highest educational attainment
High school 4 3
Trade/diploma 3 6
Bachelor degree 5 4
Postgraduate 
degree
2 2
Cultural background/ethnicityb
Australian 4 9
Southern/Eastern 
European
3
South- East Asian 1
North- East Asian 1
Southern/Central Asian
North- West 
European
2 6
North African 2
Socio- economic status of suburbc
Low 6 6
Middle 5 9
High 3
aOne juror pulled out because of illness during the jury in Sydney.
bBased on Australian Standard Classification of Cultural and Ethnic Groups 
(ASCEG).
cBased on Socio- economic Index for Area (SEIFA).
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descriptions of their institutional roles and relevant clinical experience) 
and the video presentations shown to the juries are available online.31
Immediately after each video, the expert was available by telecon-
ference call or in person for jurors to question. These question and 
answer sessions, facilitated by a researcher, allowed jurors to clarify or 
question the arguments presented.
For the first hour of Jury Day 2 (Sunday), jurors reflected on, dis-
cussed and debated the evidence, aided by a researcher acting as facil-
itator. Facilitation focused on promoting constructive dialogue and fair 
interaction amongst jurors. Juries then deliberated for an hour without 
researchers present to reach a verdict. After this hour, the researchers 
re- entered the jury room. The verdict, underpinning reasoning and dis-
senting views, were reported to the research team in a final facilitated 
feedback session; the research team focused on recording these as 
accurately as possible, constantly checking with the jurors for clarifica-
tion. The transcripts of the unfacilitated deliberation indicate that con-
structive dialogue and fair interaction continued during un- facilitated 
periods. Our research and reporting processes for these Community 
juries were cross- checked against the CJChecklist protocol.32
2.2 | Data collection and analysis
The two deliberative groups (juries) are the unit of analysis in 
this study. All jury deliberations (facilitated and un- facilitated) 
and expert question and answer sessions were audio- recorded 
and then transcribed by an independent service. During the final 
session, a researcher recorded the verdict and reasons on a flip-
chart during the course of discussion. Each point was reviewed 
by the jury to ensure accuracy and altered at their direction. The 
transcripts of all sessions were subsequently qualitatively ana-
lysed by the first two authors to identify key reasons why jurors 
prioritized, supported and/or rejected the options they consid-
ered. Open coding was used to identify the range of arguments 
and reasons put forward by the jurors in their deliberations. 
Authors one and two then used framework analysis to system-
atically map how different arguments and reasons appeared in 
the two juries, respectively.33 The findings were reviewed and 
discussed by all authors to reach consensus on interpretation.
3  | RESULTS
To recap, in their deliberations, the two juries were asked to address a 
two- part question (Box 1):
1. Part A: to identify 3 other measures to promote sustainable 
antibiotic use that they thought should be added to the list of 
seven policy interventions under consideration.
TABLE  2 Expert testimony provided to Western Sydney and Dubbo community juries
Expertise Expert area Data provided
1 Infectious disease and clinical 
microbiology
Current measures and progress towards 
changing antibiotic use in Australia
(i) Review of the regulatory landscape surrounding 
antibiotic use, and the success of otherwise of current 
measures being used to curb antibiotic misuse in 
Australia
(ii) A detailed description of the nature and mechanism 
of each of the proposed policy interventions
2 Infectious disease physician and 
clinical microbiology
Human health perspectives on managing 
AMR
(i) Review of the purpose, context and benefits and 
harms of antibiotic use in community- based human 
health- care practices
(ii) Their expert opinion as to the likely impacts and 
implications of each of the proposed policy 
 interventions for doctors, patients and the broader 
community
3 Clinical veterinary medicine and 
veterinary microbiology
Animal health perspectives on managing 
AMR
(i) Review of the purpose, context, and benefits and 
harms of antibiotic use in animal health- care practices
(ii) Their expert opinion as to the likely impacts and 
implications of each of the proposed policy 
 interventions for veterinarians, animals and the 
broader community
4 Clinical dentistry and oral biology Oral health perspectives on managing 
AMR
(i) Review of the purpose, context and benefits and 
harms of antibiotic use in dental health- care practices
(ii) Their expert opinion as to the likely impacts and 
implications of each of the proposed policy 
 interventions for dentists, patients and the broader 
community
5 Political philosophy and public 
health ethics
Ethical perspectives on managing AMR (i) The nature of different distribution systems for 
limited resources
(ii) The ethical implications of each of the proposed 
policy interventions
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2. Part B: to rank the resulting list of 10 policy interventions, from 
best to worst, and give reasons for their decisions.
3.1 | Part A
The juries in Western Sydney and Dubbo nominated similar addi-
tional policy interventions to form part of their deliberations. Both groups 
added that: (i) greater effort should be made to monitor imported foods 
for the presence of antibiotic residues and antibiotic resistant bacteria* ; 
and (ii) that greater regulatory oversight should be considered, in the form 
of new national registers of prescriber and consumer antibiotic use. While 
the jury in Sydney conceived of these prescriber and consumer surveil-
lance systems as independent entities, and therefore as two separate 
policy interventions, the jury in Dubbo proposed and strongly empha-
sized the need for a single combined prescriber and consumer register as 
a single intervention. For their third and final intervention, the jury in 
Dubbo added: (iii) measures to decrease people’s exposure to the iatro-
genic acquisition of antibiotic resistant pathogens through the minimiza-
tion of unnecessary hospital- based human health care, for example by 
avoiding speculative or low value surgical procedures and increasing the 
amount of home- based outpatient care; and minimizing inpatient expo-
sure to AMR by increasing the number of single occupancy rooms.
Interventions considered but ultimately not supported by either 
jury included the following:
1. Banning the use of antibacterial disinfectants in household cleaning 
products;
2. Banning of sales promotion for antibiotics across human and animal 
health care;
3. Mandatory warnings on antibiotic packaging; and
4. Introducing a yearly quota for each person of antibiotics sourced 
from primary care.
3.2 | Part B
Most jurors did not actively differentiate between different groups 
of prescribers (GPs, dentists and veterinarians) during their delib-
erations or in their decision making, even though they were given 
several opportunities to do so. Rather than ranking each measure 
during the unfacilitated deliberation session, both juries indepen-
dently chose to create priority categories (high priority, secondary 
priority, low priority, etc.) to which they then allocated each of the 
10 interventions (Table 2). These were to be applied across society, 
rather than being targeted to specific professional groups. Both ju-
ries justified this approach to prioritization on the basis that multiple, 
co- ordinated and interrelated interventions would be needed to ef-
fect meaningful and sustained changes in antibiotic use in Australian 
community settings.
3.3 | Reasons given for the rankings
Both juries placed a relatively high priority on efforts to educate pre-
scribers and consumers on appropriate antibiotic use, because they 
believed raising community awareness was an essential foundation for 
effective implementation of all other interventions. Acknowledging 
that efforts at communication around the issue of AMR had not previ-
ously made a substantive difference to levels of antibiotic consump-
tion in Australia, jurors thought that targeted social and on- product 
marketing campaigns could be used, in concert with more tradi-
tional forms of public health communication, to make people more 
mindful of the costs and risks of AMR. Food labelling, for example, 
could include information about the amounts of antibiotics used in 
production; antibacterial cleaning product labels could have a warn-
ing that they can promote resistance among bacteria in the environ-
ment. Jurors also noted that public messaging about antibiotic misuse 
should include alternative strategies for self- management of minor ill-
nesses—noting that unless people were equipped to respond to mild 
diseases appropriately, they would revert to established patterns of 
consumption (Table 3).
The introduction of surveillance systems and more robust restric-
tions to monitor and modify the prescribing behaviours of community- 
based practitioners was also strongly supported by both groups. Jurors 
reasoned that, as trained professionals, human and animal health- care 
providers should accept the external auditing of, and take responsi-
bility for, their prescribing decisions. Most jurors did not think these 
types of measures placed an unwarranted burden on practitioners. 
In contrast, introducing a “practitioner’s pledge” to waiting rooms or 
delayed prescribing was given a relatively low priority by both juries. 
Both groups saw the value of reminding everyone of the importance of 
changing their antibiotic use. Nevertheless, these interventions were 
not viewed favourably because jurors believed they would be largely 
unnecessary if the education campaign was effective and the new re-
strictions on prescribers were properly embedded and accepted by the 
public. They also thought that unless adopted universally, the “practi-
tioner’s pledge” and delayed prescribing would just encourage “doctor 
shopping” and punish health- care practitioners who were doing the 
right thing by their patients and the community.
The continued use of antibiotics for growth promotion in food 
production was not supported by either jury. Jurors reasoned that 
banning the non- therapeutic use of antibiotics in agriculture was 
worth the extra cost to consumers. Both juries also thought that 
stricter monitoring of imported foods for the presence of resistant 
organisms and antibiotic residues, with trade suspensions for compli-
ance failures, were necessary so that local producers were not unfairly 
disadvantaged. Both groups saw maintaining the capacity to treat 
infectious disease in animals as important. However, the Western 
Sydney jury gave a higher priority than the Dubbo jury to monitoring 
imported foods although, as a group representing a rural community, 
the latter were more likely to be adversely effected by any asymmet-
rical changes in these policies. Because the costs of banning growth 
promotants and increased monitoring of imported foodstuff would 
almost certainly be passed on to consumers, both groups thought 
*While foods imported to Australia are monitored for antibiotic residues, they are not cur-
rently monitored for antibiotic resistance.
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that the public education campaign should explain the need for these 
measures.
Finally, the juries were unanimous that introducing a tax or price 
disincentive to curb antibiotic use should not be considered, even if 
its application was limited to animal health and/or agriculture. They 
reasoned that increasing the cost of antibiotics would only deepen 
existing inequities of access to effective health care for those truly in 
need. In their reasoning jurors again noted that, if appropriate antibi-
otic prescribing was the norm, then increasing the price to reduce de-
mand could not be considered a viable policy option. Jurors were also 
concerned that placing the burden on consumers in this manner would 
not facilitate a genuine culture shift, but rather encourage secondary 
unauthorized markets in antibiotics.
4  | DISCUSSION
This study aimed to examine and compare the extent to which groups 
of informed citizens living in large metropolitan and regional/rural set-
tings would support different policy approaches to curbing the misuse 
of antibiotics in the Australian community. A range of evidence- based 
strategies have been shown to significantly reduce the unneces-
sary prescribing of antibiotics, and current evidence suggests that 
community- based practitioners have a central role in maintaining the 
efficacy of antibiotics.14,34 The current policy climate surrounding the 
implementation of Australia’s new Antimicrobial Resistance Strategy 
means that many of these measures are being trialed,35 or at least 
strongly promoted to Australian human and animal health- care pro-
viders.36,37 At the same time, the literature on the knowledge, atti-
tudes and beliefs of the general public about antibiotic resistance is 
vast and growing rapidly.38 To date, however, there has been little to 
no research as to the public acceptability and perceived legitimacy of 
policy interventions to decrease unnecessary antibiotic consumption, 
in Australia or elsewhere.39
After 2 days of information and deliberation, both juries placed a 
high priority on: (i) ensuring that the general public were better edu-
cated about AMR and their role in responding to the risks posed; and 
(ii) introducing coercive and restrictive measures that increase prac-
titioner responsibility for their antibiotic prescribing decisions. The 
overarching policy aim of both juries was to increase accountability as 
a means to curb antibiotic misuse. Jurors recommended that health- 
care providers be made much more accountable for their prescribing 
TABLE  3 The final rankings of the proposed interventions
Of highest priority for the community jury in Western Sydney Of highest priority for the community jury in Dubbo
Educate prescribers and the public on appropriate antibiotic use Create an integrated national register to monitor prescriber and consumer 
antibiotic use (proposed by Dubbo jury only)
Require GPs, veterinarians and/or dentists to write a justification on the patient’s 
record each time they prescribe antibiotics
Secondary priorities
Require GPs, veterinarians and/or dentists to write a justifica-
tion on the patient’s record each time they prescribe 
antibiotics
Educate prescribers and the public on appropriate antibiotic use
Prohibit or severely restrict community- based practitioners 
such as GPs, veterinarians and/or dentists from prescribing 
antibiotics of last resort
Prohibit or severely restrict community- based practitioners such as GPs, 
veterinarians and/or dentists from prescribing antibiotics of last resort
Create a national register to monitor “prescriber” antibiotic use 
(proposed by Sydney jury only)
Tertiary priorities
Ban the use of growth promoting antibiotics in food- producing 
animals
Minimization of hospital- based care (proposed by Dubbo jury only)
Monitoring of imported foods for the presence of resistant or-
ganisms and antibiotic residues
Ban the use of growth promoting antibiotics in food- producing animals
Low priorities
Ask GPs, veterinarians and/or dentists to hang a signed poster 
in their consulting room pledging to only prescribe antibiotics 
when they are needed
Ask GPs, veterinarians and/or dentists to hang a signed poster in their consulting 
room pledging to only prescribe antibiotics when they are needed
National register to monitor “consumer” antibiotic use 
(proposed by Sydney jury only)
Monitoring of imported foods for the presence of resistant organisms and 
antibiotic residues
Prohibit antibiotics from being dispensed on the day of 
prescription (ie, require them to be dispensed 3 or more days 
later)
Prohibit antibiotics from being dispensed on the day of prescription (ie, require 
them to be dispensed 3 or more days later)
Should not be considered
Make antibiotics significantly more expensive Make antibiotics significantly more expensive
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decisions through interventions that place restrictions on their clinical 
autonomy, systems for surveillance and active auditing of their prac-
tices, or both. This suggests that, when well- informed about the driv-
ers of AMR and risks it poses to Australia’s agricultural and health- care 
systems, members of public are open to imposing more intrusive or 
restrictive types of measures than those currently being implemented 
under the government- led package of reforms.
When given the opportunity to suggest interventions not in-
cluded in the original list of seven, both juries recommended and 
strongly supported creating an antibiotic prescribing surveillance 
system to improve accountability through monitoring health- care 
providers and giving them feedback on their prescribing behaviours. 
Indeed, both juries favoured introducing a suite of further measures 
and regulations that would act as a check on prescribers to direct 
them away from unwarranted antibiotic use. Evidence as to the effec-
tiveness of prescriber- focused interventions is limited, but growing 
rapidly,34 and the results of studies in Australia are now being pub-
lished.40 Previous reviews have found that auditing systems produce 
only small changes in prescriber behaviours when used as an isolated 
intervention.14 However, more recent empirical work in the USA and 
Scandinavia suggests that, when part of a larger suite of interven-
tions, surveillance systems that include audit, feedback and peer 
comparison did significantly reduce inappropriate antibiotic use.19,20 
The same multisite study suggested that imposing “justificatory 
mechanisms” on providers can decrease prescribing rates with only 
modest changes to practice work flows and practitioner perceptions 
of clinical autonomy.20
Introducing new restrictions on prescribers may meet with resis-
tance from some professional groups in Australia, and different models 
would be required for different health- care settings.41 However, rather 
than being an imposition on how health- care providers practice, jurors 
tended to construe promoting judicious antibiotic use as a component 
of a clinician’s responsibility to broader society. They argued that if 
steps such as the active auditing of prescribing and requiring health- 
care practitioners to write a justification on the patient record were 
properly integrated with the public education campaign, this would 
help to reinforce tighter controls on antibiotic use as part of a “whole 
of society” solution.
Other less coercive interventions and nudging techniques such 
as the practitioner’s pledge have been found to lower prescribing 
rates,21 but were not given a high priority by either jury. It is im-
portant to highlight that jurors were not “against” the waiting room 
posters, but for them these types of interventions were far less im-
portant than combining a strong regulatory environment to control 
supply with a strong effective public information environment to 
limit demand.
In general, neither group favoured patient- based interventions 
such as price increases and delayed prescribing. In human medicine 
at least, systematic reviews suggest that delayed prescribing is likely 
to be one of the most effective interventions, especially for upper 
respiratory tract infections.42 It is also perceived favourably because 
of its relatively low cost and popularity with “pressured” clinicians 
who remain uncertain which patients will benefit and concerned 
about the impacts of complications.14 A recent cross- sectional sur-
vey of 730 GPs indicates that Australian practitioners perform well 
when their knowledge of antibiotic resistance is assessed, but de-
spite this almost 40% of respondents admitted that they prescribe 
antibiotics to meet patient expectations.43 Although there is in-
creasing enthusiasm for delayed prescribing among Australian GPs 
and health researchers,40 the low priority placed on this measure by 
both juries is consistent with other studies that indicates its broader 
acceptance will require significant efforts by GPs to build trust 
and public education to highlight the need for a larger community- 
oriented response to “save” antibiotics for those who really need 
them.44,45
Any attempt to decrease consumer demand by imposing a tax 
or levy to increase antibiotic prices was completely rejected by both 
groups. However, the jurors’ aversion to imposing costs on the pub-
lic to curb antibiotic overuse was restricted to therapeutic use—for 
both human and animal patients. Jurors saw any price increase for 
consumers as being punitive because burdens would be imposed on 
those who truly needed antibiotics. Both groups were also averse to 
increasing costs for the therapeutic use of antibiotics for animals be-
cause of the risk that this would be a barrier to effective care for 
some that could result in poorer animal welfare outcomes. That said, 
both juries saw grounds for further restriction on the non- therapeutic 
use of antibiotics in animals and the creation of mechanisms—such 
as monitoring imports for antibiotic residues and resistant bacteria—
to ensure that poor practices elsewhere were not rewarded. Both 
groups were keen to make Australia a shining example in restricting 
the non- therapeutic use of antibiotics in food production use while 
also ensuring that the cost of antibiotic- free agriculture was shared 
across society.
Despite similarities in the intervention rankings, there were some 
differences in how each of the juries justified their positions. The jury 
in metropolitan Western Sydney seemed keen to emphasize a non- 
punitive form of accountability, which was closely integrated with ef-
forts towards raising public awareness about AMR. In contrast, the 
jury in regional Dubbo were more comfortable introducing more co-
ercive restrictions and punitive forms of accountability for providers 
who failed to do the right thing. When viewed in the light of the di-
lemma between the need for responsible and restrictive use of antibi-
otics on the one hand, and physicians’ obligations to their patients on 
the other, both sets of jurors were very reluctant to shift the risks and 
burdens of effective antimicrobial stewardship onto patients. For ju-
rors, it was important that any restrictive measures were implemented 
judiciously such that none acted as a barrier to timely and effective 
care.
4.1 | Limitations of the study
A limitation to this study is that community juries are comprised of 
small groups of “engaged citizens” whose views may not represent 
those of the general public. However as two juries in different set-
tings came to similar conclusions, it seems likely our findings are 
replicable.
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5  | CONCLUSION
With or without a second golden age of drug discovery, the sus-
tainable use of antibiotics is essential; to achieve this a major so-
ciocultural shift will be required that is both constitutive of and 
supported by new distribution systems that allocate this resource 
according to individual needs, population benefits, a shared con-
ception of the common good, and values such as equity and fair-
ness.16 Australia was an early leader in using regulatory measures 
to restrict the use of antibiotics of critical importance to human 
health,8 but there has been a reluctance among policymakers to 
place further restrictions on clinicians and health- care providers. 
But the juries were clear: health- care providers are best placed 
to curb antibiotic misuse and should accept further restrictions 
and auditing of their prescribing decisions for the benefit of the 
broader community.
The overarching aim of both juries, during their deliberations, was 
that policy interventions for this issue should be directed towards cre-
ating collective actions and broad social accountability for antibiotic 
use. The jury outcomes echo the basic but important observation that 
if we are to curb inappropriate antibiotic use while also ensuring access 
when antibiotics are required, then a variety of actions are needed to 
target different groups in each society.4,12 However, the jury verdicts 
also invite critical reflection by regulators and professional bodies re-
garding the role of health- care providers in facilitating or mitigating 
antibiotic overuse and misuse in community settings. Our results show 
an informed public may embrace attempts to impose stronger controls 
on prescribers to curb antibiotic misuse in the community, but this 
must be integrated into a well- organized and targeted set of policy 
interventions.
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